Active Shortage

APO-MIRABEGRON

APOTEX INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of APO-MIRABEGRON in Canada?

Yes. APO-MIRABEGRON 25MG has an active shortage reported to Health Canada (last updated September 25, 2026).

Why is APO-MIRABEGRON not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will APO-MIRABEGRON be available again?

The manufacturer's estimated resolution date is October 2, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file3 products

Expected resolution~4 days remaining (estimate)

Affected strength25MG

Last updated2026-09-25

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

MYRBETRIQ

ASTELLAS PHARMA CANADA INC

50MG · DIN 02402882

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

AURO-MIRABEGRON

AURO PHARMA INC

50MG · DIN 02564955

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

SANDOZ MIRABEGRON

SANDOZ CANADA INCORPORATED

50MG · DIN 02558483

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Estimated Resolution

2026-10-02

~4 days remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

DIN

02564963

Strength

25MG

Dosage Form

TABLET (EXTENDED-RELEASE)

Route

ORAL

Active Ingredient

MIRABEGRON

Tier

Unrated

Last Updated

2026-09-25

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

APO-MIRABEGRON has 2 shortage/discontinuation reports on file — this is one of them.

2026-06-19

Active Shortage

Disruption of the manufacture of the drug.

Other Products from APOTEX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

24HR NASAL ALLERGY RELIEF

50MCG · DIN 02460513

ACETAMINOPHEN CAPLETS 325 MG

325MG · DIN 02362341

ACETAMINOPHEN CAPLETS 500 MG

500MG · DIN 02362368

ACETAMINOPHEN HEADACHE ULTRA RELIEF

DIN 02290901

ACETAMINOPHEN TABLETS USP 325 MG

325MG · DIN 02362422

ACETAMINOPHEN TABLETS USP 500 MG

500MG · DIN 02362244